BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 69.65% | 40.00% | 9.68% | 214.71% | -5.54% |
| Total Depreciation and Amortization | -199.07% | -10.17% | -11.56% | 14.95% | 0.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.15% | 1,789.33% | 22.00% | -6.72% | -24.89% |
| Change in Net Operating Assets | -58.62% | -19.03% | -169.02% | -159.22% | 229.36% |
| Cash from Operations | -90.63% | 212.30% | -379.37% | -76.62% | 183.89% |
| Capital Expenditure | -506.25% | -415.58% | -- | -117.14% | 94.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 95.71% |
| Cash from Investing | -288.00% | -415.58% | -- | -117.14% | 95.21% |
| Total Debt Issued | -- | -- | -- | 590.98% | -41.30% |
| Total Debt Repaid | -6.12% | -52.01% | 25.53% | 19.36% | -290.54% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15,675.00% | -8,500.00% | -21.76% | -273.58% | 100.14% |
| Cash from Financing | -191.26% | -352.94% | -1.26% | 626.69% | 600.78% |
| Foreign Exchange rate Adjustments | 344.48% | -206.28% | 47.26% | 144.12% | -239.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.60% | 6.87% | -911.82% | 6,884.87% | 223.44% |
